Narender R Gavva

Narender R Gavva

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Medical Genetics
AD Scientific Index ID: 4406340
武田薬品工業株式会社
person_outline Narender R Gavva's MOST POPULAR ARTICLES
1-) Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humansNR Gavva, JJS Treanor, A Garami, L Fang, S Surapaneni, A Akrami, ...Pain 136 (1-2), 202-210, 20085042008
2-) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo [b][1, 4] dioxin-6-yl) acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic propertiesNR Gavva, R Tamir, Y Qu, L Klionsky, TJ Zhang, D Immke, J Wang, D Zhu, ...Journal of Pharmacology and Experimental Therapeutics 313 (1), 474-484, 20054122005
3-) Molecular determinants of vanilloid sensitivity in TRPV1NR Gavva, L Klionsky, Y Qu, L Shi, R Tamir, S Edenson, TJ Zhang, ...Journal of Biological Chemistry 279 (19), 20283-20295, 20044112004
4-) Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacksGY Wong, NR GavvaBrain research reviews 60 (1), 267-277, 20094172009
5-) The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulationNR Gavva, AW Bannon, S Surapaneni, DN Hovland, SG Lehto, A Gore, ...Journal of Neuroscience 27 (13), 3366-3374, 20073902007